Molecular-targeted therapy in ameloblastoma: a systematic review
{{output}}
Background: Ameloblastoma is a benign odontogenic tumor that predominantly occurs in the mandible and is frequently associated with the BRAFV600E mutation, which activates the mitogen-activated protein kinase (MAPK) signaling pat... ...